NCT00001964View on ClinicalTrials.gov

Combination Therapy of Severe Aplastic Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 17, 2000

Primary Completion Date

December 9, 2003

Study Completion Date

May 12, 2015

Conditions
Severe Aplastic Anemia
Interventions
DRUG

Cyclosporine A

Cyclosporine A

DRUG

ATG

ATG

DRUG

MMF

MMF

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001964 - Combination Therapy of Severe Aplastic Anemia | Biotech Hunter | Biotech Hunter